Long non-coding RNAs (lncRNAs) are non-coding transcripts that have emerged as one of
the largest and diverse RNA families that regulate gene expression. Accumulating evidence …

Many studies in recent years have found that dysregulation of long non-coding RNAs
(lncRNAs) can contribute to disease. Small nucleolar RNA host gene 17 (SNHG17) is a …

Emerging studies indicate that long noncoding RNAs (lncRNAs) play crucial roles in ovarian
cancer (OC). By analyzing high-throughput data, we found that SNHG17 was highly …

Background Hepatocellular carcinoma (HCC) is one of the most common types of cancer
that is associated with poor quality of life in patients and a global health burden. The …

Background Polycystic ovary syndrome (PCOS) is a complex multifactorial disorder with a
substantial genetic component. However, the clinical manifestations of PCOS are …

Physical activity is a first-line treatment for polycystic ovary syndrome (PCOS). Resistance or
aerobic exercise improves metabolic complications, reproductive outcomes, and quality of …

This article reviews recent advances in the study of microRNAs (miRNAs), long non-coding
RNAs (lncRNAs), and their functions in type 2 diabetes mellitus (T2DM), ischemic stroke (IS) …

Aim Long non-coding RNA (lncRNA) SNHG17 has been shown to participate in type 2
diabetes mellitus, while its role in gestational diabetes mellitus (GDM) is unknown. Methods …

Long non-coding RNAs (lncRNAs) have become important regulators of gene expression
because they affect a wide range of biological processes, such as cell growth, death …

Objective: Long non-coding RNA (lncRNA) SNHG17 has been shown to modulate the
biological behavior of multiple cancers (eg, colorectal and lung cancers). However, its …